Full Text View
Tabular View
No Study Results Posted
Related Studies
Odiparcil For The Prevention Of Venous Thromboembolism
This study has been completed.
Study NCT00244725   Information provided by GlaxoSmithKline

First Received on October 25, 2005.   Last Updated on November 21, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fibrillation, Atrial
Deep Vein Thrombosis
Pulmonary Embolism
Venous Thromboembolism
Additional conditions recognized in this trial
Atrial Fibrillation
Embolism
Thromboembolism
Thrombosis
Venous Thrombosis
More general conditions related to this trial
Arrhythmias, Cardiac
Cardiovascular Diseases
Embolism and Thrombosis
Heart Diseases
Lung Diseases
Pathologic Processes
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Odiparcil
Warfarin
Coumadin
More general drug interventions related to this trial
Anticoagulants
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services